RecruitingPhase 2NCT06335888

A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis

Studying Giant cell arteritis

Last synced from ClinicalTrials.gov May 10, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Insel Gruppe AG, University Hospital Bern
Principal Investigator: Britta Maurer
Department of Rheumatology and Immunology, Inselspital, University of Bern, Bern, Switzerland
Intervention: AzaFol(drug)
Enrollment: 70 enrolled
Eligibility: 50 years · All sexes
Timeline: 2025 – 2029

Study locations (1)

Department of Rheumatology and Immunology, University Hospital Bern, Inselspital, Bern, Switzerland

Collaborators

Paul Scherrer Institut, Center for Proton Therapy

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06335888 on ClinicalTrials.gov

Other trials for Giant cell arteritis

Additional recruiting or active studies for the same condition.

See all trials for Giant cell arteritis →

← Back to all trials